LNA Santé SA (EPA:LNA)
23.30
0.00 (0.00%)
At close: Jan 30, 2026
LNA Santé Market Cap
LNA Santé has a market cap or net worth of €239.1 million as of January 30, 2026. Its market cap has increased by 7.26% in one year.
Market Cap
239.10M
Enterprise Value
1.08B
Revenue
863.42M
Ranking
n/a
PE Ratio
11.49
Stock Price
€23.30
Market Cap Chart
Since June 7, 2006, LNA Santé's market cap has increased from 65.07M to 239.10M, an increase of 267.45%. That is a compound annual growth rate of 6.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 239.10M | -4.90% |
| Dec 31, 2025 | 251.42M | 2.02% |
| Dec 31, 2024 | 246.43M | 19.88% |
| Dec 29, 2023 | 205.56M | -33.91% |
| Dec 30, 2022 | 311.05M | -35.78% |
| Dec 31, 2021 | 484.34M | 2.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 117.93B |
| Sanofi | 93.18B |
| Sartorius Stedim Biotech | 18.63B |
| Eurofins Scientific SE | 11.69B |
| Genfit | 281.34M |
| Transgene | 251.37M |
| Eurobio Scientific Société anonyme | 239.12M |
| Cellectis | 236.14M |